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INTRODUCTION 
 
At the request of concerned residents and the Grafton Board of Health, the Community 
Assessment Program (CAP) of the Massachusetts Department of Public Health (MDPH), 
Center for Environmental Health conducted an evaluation of cancer incidence for the 
town of Grafton.  This evaluation was initiated based on community concerns about a 
suspected increase in the incidence of cancer, specifically among individuals living in the 
area surrounding the Wyman-Gordon Company, located in the northwest corner of the 
town.   
This investigation provides a review of the pattern of ten cancer types in the town of 
Grafton and compares their incidence with the incidence of these cancers in the state of 
Massachusetts as a whole.  Additionally, available information about risk factors, 
including environmental factors, related to the development of these cancers was 
evaluated.  The town of Grafton is divided into four smaller geographic areas or census 
tracts (CTs) and cancer incidence rates were also evaluated for each census tract 
separately with a particular focus on CT 7383, where Wyman-Gordon is located.  Cancer 
incidence data for Grafton were obtained from the Massachusetts Cancer Registry (MCR) 
for the years 1982 – 2000, the time period for which the most recent and complete data 
were available at the initiation of this analysis.  In addition, two smaller time periods 
were evaluated, 1982 – 1990 and 1991 – 2000, to assess possible trends over time.  
In addition to calculation of cancer incidence rates, a qualitative analysis of the 
geographic distribution of individuals diagnosed with each of the ten types of cancer was 
conducted by mapping their residence at time of diagnosis.  This was done to determine if 
any patterns existed in a particular area of town or in relation to the Wyman-Gordon 
company site.   
Finally, to further address resident concerns about the pattern of cancer near Wyman-
Gordon and specific reports of individual diagnoses in the adjacent neighborhood, a 
qualitative evaluation of all cancer types was conducted for the streets immediately 
surrounding the facility.   
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WYMAN-GORDON COMPANY 
 
The Wyman-Gordon Company is located on Worcester Street (Route 122) in North 
Grafton, Massachusetts (GZA 2003).  The company has been in operation since 1945 and 
manufactures metal forgings used primarily in the military and aviation industry.  Current 
operations are on a portion of a larger property located on approximately 232 acres in 
both Grafton and the adjacent town of Millbury.  Multiple contamination areas have been 
identified on the Wyman-Gordon property and they are generally associated with 
previous site use (e.g. former waste management and disposal areas or accidental spill 
releases of hazardous materials).  These contamination areas fall under the regulation of 
the Massachusetts Department of Environmental Protection (MDEP) and are at various 
stages of remediation (GZA 2003, 2004).   
 
Community environmental concerns originally focused on the identification of nitrate and 
solvent contamination in private drinking water wells along Creeper Hill Road and 
Faulkner Road located north of the Wyman-Gordon property.  Environmental 
investigations conducted at the site have identified contamination of groundwater with 
metals, nitrates, and volatile organic compounds (VOCs) including trichloroethylene 
(TCE) and tetrachloroethylene (PCE) (GZA 2003, 2004).  Prior to 1994, residences and 
commercial buildings along Creeper Hill Road and Faulkner Road in Grafton were 
served by private water supply wells; however, in June 1994 they were connected to the 
municipal water supply (GZA 1994).   
 
Community concerns have also focused on the presence of hazardous waste and 
radioactive materials on the property.  Residents have reported to MDPH that children 
have frequented contaminated areas of the property and some individuals have voiced 
concern that basement flood water in area homes may have been contaminated.  The 
nature of soil contamination varies with former site use throughout the property.  
Petroleum hydrocarbons, polychlorinated biphenyls (PCBs), VOCs, and metals have been 
identified in soil from a number of different release areas as well as in some pond 
sediment and wetland soils.  Dioxin has been detected in soils where a former refuse burn 
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area was located (GZA 2003).  Approximately 50,000 pounds of radioactive magnesium-
thorium waste is buried in unlined trenches in the northeast corner of the Wyman-Gordon 
property along Creeper Hill Road.  On- and off-site groundwater samples and exposure 
measurements taken directly above the disposal area have generally shown radiation is 
present at background levels (NRC 1993).   
METHODS FOR ANALYZING CANCER INCIDENCE 
A. Case Identification/Definition 
 
Cancer incidence data (i.e., reports of new cancer diagnoses) for the years 1982 – 2000 
were obtained for the town of Grafton from the MCR, a division of the Center for Health 
Information, Statistics, Research and Evaluation within the MDPH.  Ten cancer types 
were evaluated in this investigation, including cancers of the bladder, stomach, thyroid, 
kidney, liver, lung and bronchus, and bone as well as leukemia, multiple myeloma and 
non-Hodgkin’s lymphoma (NHL).  [Coding for cancer types in this report follows the 
International Classification of Diseases for Oncology (ICD-O) system.  See Appendix A 
for the incidence coding definitions used in this report for these cancer types.]  These 
cancer types were selected for evaluation based on elevations that were observed at the 
town level in a preliminary review of cancer rates in Grafton, potential associations with 
contaminants of concern at the Wyman-Gordon Company site (primarily TCE, PCE, 
nitrates and radioactive waste), and/or resident concern over suspected elevations of some 
cancer types.  Only cases reported to the MCR as a primary cancer for one of the ten 
cancer types and diagnosed among a resident of Grafton were included in the analysis.  
Cases were selected for inclusion based on the address reported to the hospital or 
reporting medical facility at the time of diagnosis. 
The MCR is a population-based surveillance system that began collecting information on 
Massachusetts residents diagnosed with cancer in the state in 1982.  All newly diagnosed 
cancer cases among Massachusetts residents are required by law to be reported to the 
MCR within six months of the date of diagnosis (M.G.L. c.111 s.111b).  This information 
is kept in a confidential database.  Data are collected on a daily basis and are reviewed for 
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accuracy and completeness on an annual basis.  This process corrects misclassification of 
data (i.e., city/town misassignment).  Once these steps are finished, the data for that year 
are considered “complete.”  Due to the volume of information received by the MCR, the 
large number of reporting facilities, and the six-month period between diagnosis and 
required reporting, the most current registry data that are complete will inherently be a 
minimum of two years prior to the current date.  The 19-year period 1982 – 2000 
constitutes the period for which the most recent and complete cancer incidence data were 
available from the MCR at the time of this analysis.1 
The term "cancer" is used to describe a variety of diseases associated with abnormal cell 
and tissue growth.  Epidemiologic studies have revealed that different types of cancer are 
individual diseases with separate causes, risk factors, characteristics and patterns of 
survival (Berg 1996).  Cancers are classified by the location in the body where the 
disease originated (the primary site) and the tissue or cell type of the cancer (histology).  
Therefore, each of the cancer types reviewed in this report was evaluated separately.  
Cancers that occur as the result of the metastasis or the spread of a primary site cancer to 
another location in the body are not considered as separate cancers and therefore were not 
included in this analysis.  
B. Calculation of Standardized Incidence Ratios (SIRs) 
 
To determine whether elevated numbers of cancer cases occurred in Grafton, cancer 
incidence data were tabulated by gender according to eighteen age groups to compare the 
observed number of cancer cases to the number that would be expected based on the 
statewide cancer rate.  Standardized incidence ratios (SIRs) were then calculated for the 
period 1982 – 2000 for each of the ten primary cancer types for Grafton as a whole as 
well as for each census tract (CT) within Grafton.  SIRs were also calculated for two 
smaller time periods, 1982 – 1990 and 1991 – 2000, in order to evaluate patterns or 
trends in cancer incidence over time. 
                                                 
1 The data summarized in this report are drawn from data entered on MCR computer files before June 21, 
2004.  The numbers presented in this report may change slightly in future reports, reflecting late reported 
cases, address corrections, or other changes based on subsequent details from reporting facilities. 
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In order to calculate SIRs, it is necessary to obtain accurate population information.  The 
population figures used in this analysis were interpolated based on 1980, 1990, and 2000 
U.S. census data for each CT in Grafton and for the town as a whole (U.S. DOC 1980, 
1990, and 2000).  Midpoint population estimates were calculated for each time period 
evaluated (i.e., 1986, 1991 and 1996).  To estimate the population between census years, 
an assumption was made that the change in population occurred at a constant rate 
throughout the ten-year interval between each census.2 
Because accurate age group and gender specific population data are required to calculate 
SIRs, the CT is the smallest geographic area for which cancer rates can be accurately 
calculated.  Specifically, a CT is a smaller statistical subdivision of a county as defined 
by the U.S. Census Bureau.  CTs usually contain between 2,500 and 8,000 persons and 
are designed to be homogenous with respect to population characteristics (U.S. DOC 
1990).  
According to the U.S. Census, the town of Grafton is subdivided into four census tracts 
(i.e., CTs 7381 – 7384).  Four individuals for whom census tract designation was not 
possible were included in the town totals for Grafton.  It is important to note that Grafton 
CT 7384 also encompasses areas of Shrewsbury and Westborough, as well as a part of 
Grafton (refer to Figure 1).  According to the data from the 2000 Census, less than 400 
individuals reside in the Grafton portion of CT 7384.  This small population results in 
expected numbers calculated for the ten cancer types that are equal to or close to zero for 
this CT.   
C. Interpretation of a Standardized Incidence Ratio (SIR) 
 
An SIR is an estimate of the occurrence of cancer in a population relative to what might 
be expected if the population had the same cancer experience as a larger comparison 
population designated as "normal" or average.  Usually, the state as a whole is selected to 
                                                 
2 Using slightly different population estimates or statistical methodologies, such as grouping ages 
differently or rounding off numbers at different points during calculations, may produce results slightly 
different from those published in this report. 
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be the comparison population.  Using the state of Massachusetts as a comparison 
population provides a stable population base for the calculation of incidence rates. 
Specifically, an SIR is the ratio of the observed number of cancer cases in an area to the 
expected number of cases multiplied by 100.  The population structure of each town is 
adjusted to the statewide incidence rate to calculate the number of expected cancer cases.  
The SIR is a comparison of the number of cases in the specific area (i.e., city/town or 
census tract) to the statewide rate.  Comparisons of SIRs between towns or census tracts 
are not possible because each community has different population characteristics. 
An SIR of 100 indicates that the number of cancer cases observed in the population being 
evaluated is equal to the number of cancer cases expected in the comparison or "normal" 
population.  An SIR greater than 100 indicates that more cancer cases occurred than were 
expected, and an SIR less than 100 indicates that fewer cancer cases occurred than were 
expected.  Accordingly, an SIR of 150 is interpreted as 50% more cancer cases than the 
expected number; an SIR of 90 indicates 10% fewer cancer cases than expected. 
Caution should be exercised, however, when interpreting an SIR.  The interpretation of 
an SIR depends on both the size and the stability of the SIR.  Two SIRs can have the 
same size but not the same stability.  For example, an SIR of 150 based on four expected 
cases and six observed cases indicates a 50% excess in cancer, but the excess is actually 
only two cases.  Conversely, an SIR of 150 based on 400 expected cases and 600 
observed cases represents the same 50% excess in cancer, but because the SIR is based 
upon a greater number of cases, the estimate is more stable.  It is very unlikely that 200 
excess cases of cancer would occur by chance alone.  As a result of the instability of 
incidence rates based on small numbers of cases, SIRs were not calculated when fewer 
than five cases were observed for a particular cancer type. 
D. Calculation of the 95% Confidence Interval 
 
To help interpret or measure the stability of an SIR, the statistical significance of each 
SIR was assessed by calculating a 95% confidence interval (95% CI) to determine if the 
observed number of cases is “significantly different” from the expected number or if the 
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difference may be due solely to chance (Rothman and Boice 1982).  Specifically, a 95% 
CI is the range of estimated SIR values that have a 95% probability of including the true 
SIR for the population.  If the 95% CI range does not include the value 100, then the 
study population is significantly different from the comparison or "normal" population.  
"Significantly different" means there is less than a 5% chance that the observed 
difference (either increase or decrease) is the result of random fluctuation in the number 
of observed cancer cases. 
For example, if a confidence interval does not include 100 and the interval is above 100 
(e.g., 105–130), there is statistically significant excess in the number of cancer cases.  
Similarly, if the confidence interval does not include 100 and the interval is below 100 
(e.g., 45–96), the number of cancer cases is statistically significantly lower than expected.  
If the confidence interval range includes 100, the true SIR may be 100.  In this case, it 
cannot be determined with certainty that the difference between the observed and 
expected number of cases reflects a real cancer increase or decrease or is the result of 
chance.  It is important to note that statistical significance does not necessarily imply 
public health significance.  Determination of statistical significance is just one tool used 
to interpret SIRs. 
In addition to the range of the estimates contained in the confidence interval, the width of 
the confidence interval also reflects the stability of the SIR estimate.  For example, a 
narrow confidence interval, such as 103–115, allows a fair level of certainty that the 
calculated SIR is close to the true SIR for the population.  A wide interval, for instance 
85–450, leaves considerable doubt about the true SIR, which could be much lower than 
or much higher than the calculated SIR.  This would indicate an unstable statistic.  Again, 
due to the instability of incidence rates based on small numbers of cases, statistical 
significance was not assessed when fewer than five cases were observed. 
E. Evaluation of Cancer Risk Factor Information 
 
Available information reported to the MCR related to risk factors for cancer development 
was reviewed and compared to known or established incidence patterns for the cancer 
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types evaluated in this report.  This information is collected for each individual at the 
time of cancer diagnosis and includes age at diagnosis, stage of disease, smoking history 
and occupation.  One or even several factors acting over time can be related to the 
development of cancer.  For example, tobacco use has been linked to lung and bronchus, 
bladder, and kidney cancers.  Other cancer risk factors may include lack of crude fiber in 
the diet, high fat consumption, alcohol abuse, and reproductive history.  Heredity, or 
family history, is an important factor for several cancers.  To a lesser extent, some 
occupational exposures, such as jobs involving contact with asbestos, have been shown to 
be carcinogenic (cancer causing).  Environmental contaminants have also been associated 
with certain types of cancer.  Available information from the MCR related to age and 
gender, as well as other factors related to the development of cancer such as smoking and 
occupation, was reviewed for those cancer types that had statistically significant 
elevations in incidence in Grafton.  These cancer types included NHL and bladder cancer.  
However, information about personal risk factors such as family history, hormonal 
events, diet, and other factors that may also influence the development of cancer is not 
collected by the MCR, and therefore, it was not possible to evaluate them in this 
investigation. 
F. Determination of Geographic Distribution of Cancer Cases 
 
In addition to calculation of SIRs, address at the time of diagnosis for each individual 
diagnosed with one of the ten cancer types was mapped using a computerized geographic 
information system (GIS) (ESRI 2002).  This allowed assignment of census tract location 
as well as an evaluation of the spatial distribution of individuals at a smaller geographic 
level (i.e., neighborhoods).  The geographic pattern was determined using a qualitative 
evaluation of the point pattern of cancer diagnoses.  In instances where the address 
information from the MCR was incomplete (i.e., did not include specific streets or street 
numbers), efforts were made to research those cases using telephone books issued within 
two years of an individual's diagnosis.  For confidentiality reasons, it is not possible to 
include maps showing the locations of individuals diagnosed with cancer in this report.  
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[Note: MDPH is bound by law not to reveal the name or identifying information of an 
individual diagnosed with cancer and reported to the MCR.] 
G. Cancer Incidence in the Wyman-Gordon Neighborhood 
 
Specific information on several Grafton residents diagnosed with cancer was provided to 
the MDPH from residents along with concerns about the Wyman-Gordon Company.  
Although it is not possible to calculate incidence rates beyond the year 2000 (i.e., the year 
for which complete data are available), the MCR is a continual surveillance system for 
cancer and it is possible to review case reports for more recent years (i.e., 2001 – 
present).  Therefore, to address specific community concerns about a suspected increase 
in cancer incidence in neighborhoods in close proximity to the Wyman-Gordon Company 
site, MCR data files for residents who had been diagnosed with any cancer type from 
1982 to the present were reviewed qualitatively for this area of Grafton.  Specifically, to 
determine whether any cancer type appeared to be concentrated within this area of North 
Grafton, place of residence at the time of diagnosis was mapped and evaluated for all 
individuals diagnosed with cancer in the area that is bordered to the north by the 
Shrewsbury town line, to the northwest by the city of Worcester, to the west by the town 
of Millbury, to the south by Interstate 90 and Hovey Pond to the east (see Figures 1 and 
2).  As previously stated, for confidentiality reasons, maps of the location of individuals 
diagnosed with cancer cannot be provided in this report. 
RESULTS OF CANCER INCIDENCE ANALYSIS 
 
The following sections present cancer incidence rates for Grafton and its individual 
census tracts during the 19-year time period 1982 – 2000.  A focus was placed on census 
tract 7383 where the Wyman-Gordon Company site is located.  To evaluate possible 
trends over time, these data were also analyzed by two smaller time periods, 1982 – 1990 
and 1991 – 2000.  SIRs were not calculated for some cancer types in smaller time periods 
due to the small number of observed cases (less than five).  However, the expected 
number of cases was calculated during each time period, and the observed and expected 
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numbers of cases were compared to determine whether excess numbers of cancer cases 
were occurring. 
H. Cancer Incidence in Grafton 
 
Of the ten cancer types evaluated in the town of Grafton as a whole, the majority 
occurred approximately equal to or less than expected during the 19-year time period 
1982 – 2000 (see Tables 1a through 10c).  Specifically, cancers of the bone, kidney, liver, 
lung and bronchus, stomach, and thyroid occurred at about or below the rates expected 
among males and females combined during 1982 – 2000.  Slight elevations were noted in 
the incidence of bladder cancer, leukemia, multiple myeloma, and NHL among males and 
females combined during this time period; however none of the elevations were 
statistically significant.  When evaluated separately by gender, a statistically significant 
elevation of NHL was observed among males during 1982 – 2000.  Several non-
statistically significant elevations were also observed.  Specifically, bladder cancer and 
multiple myeloma were elevated among males, and leukemia incidence was elevated 
among females.  When evaluated by the two smaller time periods, 1982 – 1990 and 1991 
– 2000, similar trends in cancer incidence were observed however, none of the cancers 
analyzed were consistently elevated over time.  Results of the cancer incidence analyses 
for each of the ten cancer types evaluated for the town of Grafton as a whole are 
described in more detail below.   
1. Bladder Cancer 
 
During the 19-year time period 1982 – 2000, bladder cancer occurred slightly more often 
than expected among residents of Grafton.  Specifically, there were 44 diagnoses among 
males and females combined compared to 40.6 expected (SIR = 108).  The overall rate 
was due to an elevation in incidence among males in the town (36 diagnoses observed vs. 
30.0 expected, SIR = 120).  Females were diagnosed less often than expected (8 
diagnoses observed vs. 10.6 expected, SIR = 76).  See Table 1a.  
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As shown in Tables 1b and 1c, the incidence of bladder cancer appears to have decreased 
over time among both male and female residents of Grafton.  During 1982 – 1990, 
statistically significant elevations in the incidence of bladder cancer were observed 
among males and females combined (34 diagnoses observed vs. 18.9 expected, SIR = 
180, 95% CI = 125-252) and among males when evaluated separately by gender (29 
diagnoses observed vs. 14.0 expected, SIR = 208, 95% CI = 139-299).  During the most 
recent time period evaluated, 1991 – 2000, bladder cancer occurred about half as often as 
expected based on the statewide experience.  Specifically, 10 individuals were diagnosed 
with bladder cancer compared to 21.2 diagnoses expected (SIR = 47).  Moreover the 
incidence was statistically significantly lower than expected (95% CI = 23-87).  Similar 
trends were observed among males and females when evaluated separately by gender.  
Males in Grafton were diagnosed statistically significantly less often than expected 
during 1991 – 2000 (7 diagnoses observed vs. 15.6 expected, SIR = 45, 95% CI = 18-93).  
Females were also diagnosed less often than expected during this time period (3 
diagnoses observed vs. 5.6 expected).  
2. Bone Cancer 
 
There were no diagnoses of bone cancer diagnosed among residents of Grafton during the 
19-year time period, 1982 – 2000, compared to 2.5 diagnoses expected (Tables 2a – 2c).  
3. Kidney Cancer 
 
The incidence of kidney cancer occurred as expected in the town of Grafton as a whole 
during the 19-year time period 1982-2000 (25 observed diagnoses vs. 25.2 expected, SIR 
= 99).  This was also true when males and females were evaluated separately.  
Specifically, for males, the number of observed diagnoses was 16 versus 15.7 expected, 
and for females, nine diagnoses were observed versus 9.6 expected.  Refer to Table 3a.   
When cancer incidence was examined for the smaller time periods, no trends were 
apparent among individuals diagnosed with kidney cancer in the town as a whole.  
Slightly more individuals were diagnosed with kidney cancer than expected during the 
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1982 – 1990 time period (12 observed vs. 9.4 expected, SIR = 127).  This was due to an 
elevation among females (6 diagnoses observed vs. 3.6 expected, SIR = 165).  Neither 
elevation was statistically significant.  Males were diagnosed at about the rate expected (6 
diagnoses observed vs. 5.8 expected, SIR = 104).  During the 1991 – 2000 time period, 
the incidence of kidney cancer among males and females combined was slightly below 
expected (13 diagnoses observed vs. 15.8 expected).  Refer to Tables 3b and 3c.  
4. Leukemia 
 
The incidence of leukemia was slightly elevated in the town of Grafton as a whole during 
1982 – 2000 (25 diagnoses observed vs. 22 expected, SIR = 114).  The observed 
elevation was largely due to an increase in diagnoses among residents of CT 7382, as 
discussed in Section IV.B of this report, but was not statistically significant.  This is not 
the census tract where the Wyman-Gordon facility is located.  Leukemia was diagnosed 
more often than expected among males and females combined during the earlier time 
period 1982 – 1990, (15 diagnoses observed vs. 8.6 expected, SIR = 175), but the 
elevation did not reach the level of statistical significance (95% CI = 98-289).  In the 
more recent time period (1991 – 2000), the incidence of leukemia in Grafton occurred 
less often than expected for males, and at about the rate expected among females.  
Specifically, there were four diagnoses observed among males compared to 7.6 expected.  
Among females, there were 6 diagnoses observed and 5.9 expected.  See Tables 4b – 4c.  
There are four major types of leukemia: acute lymphoid leukemia (ALL), acute myeloid 
leukemia (AML), chronic lymphoid leukemia (CLL), and chronic myeloid leukemia 
(CML).  There are also several rare types of leukemia (e.g., hairy cell leukemia, 
myelomonocytic leukemia).  In adults, the most common types are AML and CLL.  
Leukemia is the most common type of childhood cancer, accounting for more than 30% 
of all cancers diagnosed in children.  The majority of these cases are of the ALL type 
(ACS 2003).  The various subtypes of leukemia are thought to represent different 
diseases and occur with different frequencies in the population.  In the state of 
Massachusetts during the time period 1982–2000, 34% of all leukemia cases were AML, 
26% were CLL, 13% were ALL, 11% were CML, and 16% were other histology types. 
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Of the 25 individuals diagnosed with leukemia in Grafton during 1982 – 2000, 32% were 
diagnosed with the AML sub-type, 28% were diagnosed with CLL, 16 % were diagnosed 
with ALL, 12% were diagnosed with CML, and 12% were diagnosed with other types of 
leukemia.  This distribution is similar to that seen statewide.   
5. Liver Cancer  
 
The incidence of liver cancer occurred slightly less than expected for the town of 
Grafton, when compared to the state for the overall time period, 1982 – 2000 (5 
diagnoses observed vs. 6.2 expected, SIR = 81) (see Table 5a).     
One diagnosis occurred during the first time period 1982 – 1990, which was slightly less 
than expected (1 diagnosis observed vs. 2 expected).  The majority of individuals 
diagnosed with liver cancer during the most recent time period 1991 – 2000 were males 
(4 individuals observed vs. 4.2 expected).  Refer to Tables 5a – 5c for a summary of this 
information.   
6. Lung and Bronchus Cancer 
 
During the 19-year time period, 1982 – 2000, the incidence of lung and bronchus cancer 
occurred at approximately the rates expected in the town of Grafton.  Specifically, among 
males and females combined, 156 diagnoses were observed whereas 157.5 were expected 
(SIR = 99) (Table 6a).  Lung and bronchus cancer also occurred near the rates expected 
when males and females were evaluated separately.  Specifically, among males, 91 
diagnoses were observed whereas 94.5 would be expected (SIR = 96).  Among females, 
65 diagnoses were observed versus 63.0 expected (SIR = 103).   
The incidence of lung and bronchus cancer also occurred as expected for the two smaller 
time periods. In the earlier time period, 1982 – 1990, 65 individuals were diagnosed 
while 65.3 diagnoses were expected (SIR = 100).  This trend is consistent among both 
males and females and within the most recent time period.  From 1991 – 2000, 91 
individuals were diagnosed and 91.3 diagnoses were expected (SIR = 100) (see Tables 6b 
– 6c).  
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7. Multiple Myeloma 
 
The incidence of multiple myeloma in the town of Grafton occurred slightly more often 
than expected for the time period 1982 – 2000 (12 diagnoses observed versus 9.2 
expected, SIR = 130) (refer to Table 7a).  This was due to an elevation that occurred 
among males during this time period (7 diagnoses observed vs. 4.8 expected, SIR = 145).  
Neither elevation was statistically significant.  Females experienced multiple myeloma at 
approximately the rate expected during 1982 – 2000 (5 diagnoses observed vs. 4.4 
expected).  
For the earlier time period (i.e., 1982 – 1990), the incidence of multiple myeloma 
occurred at the rate expected for the town of Grafton as a whole (4 diagnoses observed 
vs. 3.9 expected).  However, all four individuals diagnosed with multiple myeloma were 
males and no females were diagnosed during this time period, compared to two diagnoses 
each expected among males and females.  More females were diagnosed with multiple 
myeloma than expected during the most recent time period, 1991 – 2000 (5 diagnoses 
observed vs. 2.5 expected, SIR = 200), but this elevation was not statistically significant.  
Males were diagnosed at the rate expected during this time period (3 diagnoses observed 
vs. 2.8 expected) (see Table 7b and 7c).  
8. Non-Hodgkin’s Lymphoma 
 
The incidence of NHL was elevated in the town of Grafton as a whole during 1982 – 
2000.  Specifically, 45 individuals were diagnosed with NHL compared to 38.6 expected 
(SIR = 117) (see Table 8a).  Moreover, males in Grafton experienced a statistically 
significant elevation in the incidence of this cancer type (31 diagnoses observed vs. 20.8 
expected, SIR = 148, 95% CI = 101-211).  The overall elevation observed during 1982 – 
2000 was largely attributed to a statistically significant elevation in the incidence of this 
cancer type among males during the more recent time period 1991 – 2000 (24 diagnoses 
observed vs. 13.0 expected, SIR = 185, 95% CI = 118-275).  The incidence of NHL was 
about as expected during the earlier time period, 1982 – 1990 (13 diagnoses observed vs. 
14.5 expected).  The number of females diagnosed with NHL was less than expected 
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during 1982 – 2000 and during the two smaller time periods evaluated (see Tables 8a – 
8c).  
9. Stomach Cancer 
 
Stomach cancer occurred slightly less than expected in the town of Grafton during 1982 – 
2000 based on the statewide cancer experience (18 diagnoses observed vs. 21.0 expected, 
SIR = 86).  When evaluated separately by gender, stomach cancer occurred 
approximately equal to the rate expected among males, and less often among females 
than expected during this time.   
When the smaller time periods were evaluated in comparison to the state, the number of 
observed diagnoses for males and females combined was equal to or lower than expected.  
During the first time period, 1982 – 1990, seven individuals were diagnosed with 
stomach cancer whereas 9.9 diagnoses were expected.  The incidence for males and 
females combined was as expected in the later time period (i.e., 1991 – 2000).   
Specifically, eleven individuals were diagnosed with stomach cancer and 10.9 diagnoses 
were expected during this time period.  The incidence of stomach cancer in Grafton 
appears to have increased slightly over time among males while remaining constant over 
time among females (see Tables 9a – 9c).   
10. Thyroid Cancer 
 
The incidence of thyroid cancer in Grafton was consistent with what would be expected 
for the time period 1982 – 2000.   Specifically, 12 individuals were diagnosed with 
thyroid cancer versus 12.3 expected (SIR = 98).  Females were diagnosed (8 diagnoses 
observed vs. 8.9 expected) more than males (4 diagnoses observed vs. 3.4 expected) 
during this time period.  However, this is consistent with the statewide incidence patterns 
for this cancer type (see Table 10a).   
Overall during 1982 – 1990, two diagnoses were observed compared to about four 
diagnoses expected.  During 1991 – 2000, ten individuals were diagnosed with this 
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cancer type compared to 8.6 expected.  The observed elevation was not statistically 
significant (see Tables 10b – 10c).   
I. Cancer Incidence in Grafton Census Tracts 
 
In general, with some exceptions noted below, residents of most Grafton census tracts 
experienced cancer approximately at or near the rates expected during 1982 – 2000 and 
during the smaller time periods evaluated in this report.  Census tract 7384 had no 
observed cases of cancer of any of the cancer types examined, which is what would be 
expected based on comparison to the state.  As previously noted, CT 7384 contains 
portions of Shrewsbury and Westborough and the number of individuals residing in the 
Grafton portion of this census tract is small.   
1. Bladder Cancer 
During the 19-year time period 1982 – 2000, there were slight elevations in the incidence 
of bladder cancer among residents of CTs 7381 and 7382.  These were due to increased 
elevations among males in each of these CTs.  In CT 7382, 21 males were diagnosed with 
bladder cancer compared to 14.8 expected (SIR = 142).  This elevation was not 
statistically significant.  The incidence of bladder cancer was below the rate expected in 
CT 7383 (where Wyman-Gordon is located) for the overall time period (8 diagnoses 
observed vs. 11.2 expected).  Additionally, incidence was approximately at or below 
expected for females in CTs 7381, 7382 and 7383 as well as for males in CT 7383.  See 
Table 1a. 
A statistically significant elevation in the incidence of bladder cancer was observed for 
males and females combined in CT 7382 during the earlier time period 1982 – 1990 (19 
diagnoses observed vs. 9 expected, SIR = 212, 95% CI 127-330).  This elevation was due 
to a statistically significant elevation among males during this time (16 diagnoses 
observed vs. 6.6 expected, SIR = 243, 95% CI = 139-394).  Bladder cancer was also 
slightly elevated among males in CTs 7381 and 7383 during 1982 – 1990, although 
neither elevation was statistically significant.  There were fewer diagnoses of bladder 
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cancer than expected in the more recent time period, 1991 – 2000, in each of Grafton’s 
four census tracts (see Tables 1b – 1c).   
2. Bone Cancer 
As noted above, there were no diagnoses of bone cancer among residents of Grafton 
during 1982 – 2000.  See Tables 2a – 2c. 
3. Kidney Cancer 
Kidney cancer generally occurred about as expected in Grafton CTs 7381, 7382, 7383, 
and 7384 during 1982 – 2000 (see Table 3a).  When males and females were evaluated 
separately, slightly more males were diagnosed with kidney cancer than expected in CTs 
7381 and 7382.  Specifically, in CT 7381, five males were diagnosed with kidney cancer, 
while 3.3 diagnoses were expected (SIR = 151).  In CT 7382, nine diagnoses were 
observed and 8.0 were expected (SIR = 113).  Neither elevation was statistically 
significant.  In CT 7383, where Wyman-Gordon is located, the incidence of kidney 
cancer occurred at the rate expected among males and females combined during 1982 – 
2000 and during each of the two smaller time periods.  However, when evaluated 
separately by gender, the incidence of kidney cancer was slightly lower than expected 
among males and slightly greater than expected among females.  Specifically, between 
1982 – 2000, the incidence of kidney cancer among males was 2 diagnoses versus 4.4 
expected and among females, 5 diagnoses versus 2.5 expected in CT 7383.  Similar 
trends occurred in both smaller time periods (see Table 3b and 3c).    
4. Leukemia 
The incidence of leukemia was slightly elevated with respect to the state in one Grafton 
census tract (CT 7382) during the overall time period 1982 – 2000 (15 diagnoses 
observed vs. 11.2 expected, SIR = 134).  However, this increase was not statistically 
significant (see Table 4a).  The observed elevation was largely due to an increase during 
the 1982 – 1990 time period, which was also not statistically significant (8 diagnoses 
observed vs. 4.2 expected, SIR = 191).  During the most recent time period, the incidence 
of leukemia in CT 7382 occurred at the rate expected.  Additionally, these individuals 
 18
were diagnosed with different sub-types, which as previously mentioned, are thought to 
represent different diseases and occur with different frequencies in the population.   In 
CT 7383, leukemia occurred approximately at or below the rates expected during 1982 – 
2000 and the two smaller time periods.  Refer to Tables 4b and 4c. 
5. Liver Cancer 
The incidence of liver cancer occurred at or slightly below what would be expected in all 
Grafton census tracts during the 19-year time period, 1982 – 2000.  One individual was 
diagnosed with liver cancer in the town of Grafton as a whole during the earlier time 
period 1982 – 1990.  This individual lived in CT 7383 at the time of diagnosis.  Four 
diagnoses were reported in the later time period, with three individuals residing in CT 
7382 and one in CT 7383.  No diagnoses of liver cancer occurred in CT 7381 during 
either time period.  Refer to Tables 5a – 5c for a summary of these data. 
6. Lung and Bronchus Cancer 
Lung and bronchus cancer occurred approximately as expected during 1982 – 2000 in 
each of the Grafton census tracts (see Table 6a).  During the earlier time period 1982 – 
1990, both CTs 7381 and 7383 had a lower incidence of lung and bronchus cancer than 
expected.  Specifically, in CT 7381, there were 10 observed diagnoses versus 15.7 
expected (SIR = 64).  In CT 7383, where Wyman-Gordon is located, 18 individuals were 
diagnosed with lung and bronchus cancer compared to 18.8 diagnoses expected (SIR = 
96).  The SIR for lung and bronchus cancer was elevated in CT 7382 (37 diagnoses 
observed vs. 30.8 expected, SIR = 120).  However, this elevation was not statistically 
significant.  In contrast to trends observed during the first time period, lung and bronchus 
cancer was slightly elevated among males and females in CT 7381 during 1991 – 2000.  
Specifically, in CT 7381, there were 25 individuals diagnosed with lung and bronchus 
cancer versus 18.9 expected, SIR = 132.  This elevation was not statistically significant.  
In CT 7383, lung and bronchus cancer occurred about as expected during 1991 – 2000 
(25 diagnoses were observed versus 23.8 expected, SIR = 105). Refer to Tables 6a – 6c.   
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7. Multiple Myeloma 
During the 19-year time period 1982 – 2000, no individuals were diagnosed with multiple 
myeloma in CT 7383, where Wyman-Gordon is located, compared to about 2.5 diagnoses 
expected.  Multiple myeloma was slightly elevated in both census tracts 7381 and 7382 
among males and females combined during the overall time period (refer to Table 7a).  
However, neither of these elevations was statistically significant.   
During the 1982 – 1990 time period, four males and no females were diagnosed with 
multiple myeloma.  Two of the males lived in CT 7381 and two lived in CT 7382.  
During the more recent time period 1991 – 2000, the incidence of multiple myeloma was 
slightly elevated with respect to the state rate among both males and females combined in 
census tracts 7381 and 7382.  These elevations were not statistically significant.  See 
Tables 7b and 7c.  
8. Non-Hodgkin’s Lymphoma 
As previously stated, the town of Grafton had a statistically significant elevation in the 
incidence of NHL among males from 1982 – 2000 (31 diagnoses observed vs. 20.8 
expected, SIR = 149, 95% CI 101-211).  This elevation was largely due to non-
statistically significant elevations in the incidence of this cancer type among males in 
CTs 7381, 7382 and 7383.  In CT 7381, six males were diagnosed with NHL, while 4.4 
diagnoses were expected (SIR = 136).  In CT 7382, 15 males were diagnosed with NHL 
from 1982 – 2000 whereas 10.7 were expected (SIR = 140).  In CT 7383, where Wyman-
Gordon is located, there were 10 diagnoses observed among males versus 5.7 expected, 
SIR = 176.  Females in each of these census tracts were diagnosed with NHL 
approximately as or less often than expected during 1982 – 2000 (see Table 8a).  
During the earlier 1982 – 1990 time period, the number of individuals diagnosed with 
NHL was approximately equal to the number of expected in all Grafton census tracts.  In 
the most recent time period, 1991 – 2000, a statistically significant elevation was 
observed in CT 7383 among males (8 diagnoses observed vs. 3.3 expected, SIR = 243, 
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95% CI 105-479).  Slight elevations were also noted among males and females combined 
in CTs 7381 and 7382 during this time period.  See Tables 8b and 8c.  
9. Stomach Cancer 
Stomach cancer occurred slightly less often than expected in Grafton CTs 7381 and 7382 
and approximately as expected in CT 7383, where Wyman-Gordon is located, during the 
19-year time period 1982 – 2000 (refer to Table 9a).  Specifically, in CT 7381, among 
males and females combined, there were three diagnoses observed versus 4.9 expected.  
In CT 7382, nine diagnoses were observed and 10.4 were expected (SIR = 86).  Six 
stomach cancer diagnoses were observed among residents of CT 7383, while 5.7 were 
expected (SIR = 105).  See Table 9a. 
When incidence was evaluated by smaller time periods, no diagnoses of stomach cancer 
were reported in CT 7381 during 1982-1990.  The number of observed diagnoses of 
stomach cancer in the other census tracts was approximately equal to what was expected.  
During the more recent time period 1991 – 2000, stomach cancer occurred about as 
expected in all census tracts (see Tables 9b and 9c).  
10.   Thyroid Cancer 
Thyroid cancer occurred about as expected in Grafton CTs 7381, 7382 and 7383 during 
the 19-year time period 1982 – 2000 (Table 10a).  When evaluated by gender, the 
incidence of thyroid cancer occurred about as expected for males and females separately.  
No males were diagnosed with thyroid cancer during the 19-year time period in CT 7383, 
where Wyman-Gordon is located.  The incidence among females occurred about as 
expected in this census tract between 1982 – 2000 (3 diagnoses observed vs. 2.2 
expected).  
During the earlier time period 1982 – 1990 no males were diagnosed with thyroid cancer 
in Grafton as a whole.  Two females were diagnosed during this time period, one in CT 
7382 (vs. two expected) and one in CT 7383 (vs. one expected).  Although the number of 
individuals diagnosed with thyroid cancer increased town-wide from the earlier time 
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period to the later time period, this cancer type generally occurred approximately as 
expected when evaluated by census tract.   
J. Review of Cancer Risk Factor Information 
 
Studies have generally shown that different cancer types have different causes, patterns 
of incidence, risk factors, latency periods (period between exposure and development of 
disease), characteristics, and trends in survival.  Available information from the MCR 
related to age and gender, as well as other factors related to the development of cancer 
such as smoking and occupation, was reviewed for those cancer types that had 
statistically significant elevations in incidence in Grafton, specifically, bladder cancer and 
NHL.  Information for both of these cancer types was compared to known or established 
incidence trends to assess whether any unexpected patterns exist among these cases.  For 
detailed information regarding risk factors associated with these cancer types please refer 
to Appendix B. 
Tobacco use is a known or suggested causal risk factor in several types of cancer, 
including bladder cancer.  Personal history of smoking for individuals diagnosed with 
this cancer type in Grafton during the years 1982 – 2000 was reviewed.  However, results 
of smoking status analysis should be interpreted with caution because of the number of 
individuals for which smoking status was unknown. 
In some studies, an association has been found with exposures to specific occupations 
and an increase in incidence of bladder cancer and NHL.  Therefore, occupational 
information as reported by the MCR at the time of diagnosis was reviewed for individuals 
diagnosed with these two cancer types in Grafton to determine the role that occupational 
factors may have played in the development of these cancers.  It should be noted, 
however, that occupational data reported to the MCR are generally limited to job title and 
often do not include specific job duty information that could further define exposure 
potential for individuals.  Further, these data are often incomplete as occupational 
information can be reported as unknown, at home, or retired. 
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1. Bladder Cancer 
 
To better characterize the incidence patterns of bladder cancer in Grafton, available data 
on individual risk factors from the MCR was reviewed.  This section describes the review 
of information related to age and gender, smoking, and occupation.  
a) Age and Gender  
 
Age and gender are important risk factors in the development of bladder cancer.  The risk 
of bladder cancer increases with age and the average age of diagnosis is 68-69 years.  
Furthermore, according to the American Cancer Society (ACS), males are more likely to 
develop bladder cancer than females.  During 1982 – 2000, the observed age and gender 
distribution of individuals diagnosed with bladder cancer in Grafton was consistent with 
this trend, as the average age of diagnosis among Grafton residents was approximately 69 
years and 82% of individuals diagnosed were males.   
For the earlier 1982 – 1990 time period, there was a statistically significant elevation in 
the incidence of bladder cancer among males in the town as a whole.  The average age of 
diagnosis for males during this time was 69 years.  Similar trends were observed in 
Grafton census tracts where elevations in this cancer type were observed.  Among males 
in CT 7382 where a statistically significant elevation in the incidence of bladder cancer 
was observed during this time period, the average age of individuals diagnosed was 72 
years.   
b) Smoking History 
 
Because cigarette smoking is the most well-established risk factor for the development of 
bladder cancer, smoking history was reviewed for each individual diagnosed with this 
cancer type in Grafton, including CT 7382 where a statistically significant elevation in 
bladder cancer incidence occurred among males.  Approximately 25-60% of all bladder 
cancers can be attributed to tobacco use (Johansson and Cohen, 1997).  Of the 44 
individuals diagnosed with bladder cancer in Grafton during 1982 – 2000, 72% of those 
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with known smoking history were current/former smokers (n = 28).  This is a larger 
percentage than the 67% of individuals diagnosed with bladder cancer in Massachusetts 
during the same time period with known smoking history who were current/former 
smokers.  Therefore, smoking appears to have played a greater role in the incidence of 
bladder cancer among residents of Grafton in comparison to the state as a whole.   
c) Occupation 
 
Occupational exposure to certain chemicals common in the dye industry (e.g., aromatic 
amines) is associated with the development of bladder cancer.  A higher risk of bladder 
cancer has also been observed among aromatic amine manufacturers as well as among 
workers in the rubber, leather, textiles, printing, and paint products industries (ACS, 
2000; Silverman et al., 1996).  A review of occupational information reported to the 
MCR for individuals diagnosed with bladder cancer in Grafton during 1982 – 2000 
indicated that three individuals had an occupation where job exposures thought to 
increase the risk of bladder cancer might have been possible.  No one else reported 
working jobs in which occupational exposures related to bladder cancer would have been 
likely.  However, occupation was unknown or reported as retired or “at home” for 23% of 
individuals in Grafton diagnosed with bladder cancer during 1982 – 2000.  Therefore, 
although the information reviewed suggests the possibility that occupational exposures 
may have contributed to the development of bladder cancer among some individuals, it is 
difficult to determine what role, if any, occupational exposures played in the incidence of 
bladder cancer in Grafton overall. 
2. NHL 
 
The exact causes of NHL are unknown, however, a number of risk factors have been 
associated with this disease.  Besides age, gender and race, the most important risk 
factors for NHL include conditions that suppress the immune system and viral infections 
(Scherr and Mueller, 1996).  Certain occupational exposures have also been suggested as 
having an increased risk of NHL.  Previous chemotherapy combined with radiation has 
been associated with the development of NHL (Schottenfeld and Fraumeni, 1996).  Ionizing 
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radiation has induced lymphomas in animals.  One study of Japanese atomic bomb survivors 
found an elevation of NHL in persons who were under 25 years of age at exposure; 
however, this excess did not appear until 14 to 16 years after exposure.  Certain therapeutic 
radiation treatments have also been associated with the development of NHL (Schottenfeld 
and Fraumeni, 1996).     
In order to better understand the pattern of NHL incidence in Grafton, available 
information from the MCR related to risk factors for individuals diagnosed with this 
cancer were evaluated.  Such information included individual case information relating to 
age at diagnosis, histology (cancer cell type), and occupation.  The information was 
compared to established incidence trends to determine whether an atypical pattern of 
NHL might exist.  As previously stated, one or even several factors acting over time can 
be related to the development of cancer.  However, information about personal risk 
factors that may also influence the development of NHL (e.g., conditions that suppress 
the immune system, exposure to the Epstein-Barr Virus) are not collected by the MCR or 
any other readily accessible source, and therefore, could not be evaluated in this 
investigation. 
a) Age and Gender 
 
NHL can affect people of all ages, although the incidence of NHL increases with age.  In 
Massachusetts, incidence rates of NHL begin to increase in the 45 to 64 year age group 
and are highest in the 75 to 84 year age group.  The majority of individuals 
(approximately 78%) diagnosed with NHL between the years 1982 – 2000 in Grafton 
were aged 50 and older and the average age of diagnosis was approximately 62 years.  In 
CT 7383, where a statistically significant elevation occurred in the incidence of NHL 
among males during the later time period, 75% were over 50 years old at diagnosis and  
the average age at diagnosis for males was approximately 64 years old.      
In addition, all types of NHL occur more frequently among males compared to females 
(NCI, 1996b).  Review of gender of individuals diagnosed with NHL in Grafton between 
the years 1982 – 2000 was consistent with this trend; approximately 69% were males.   
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b) Histology 
 
In general, each diagnosis of cancer is classified by its histology, which is the tissue or 
cell type of the cancer.  Tumors that develop as a result of NHL consist of abnormal, 
malignant lymphoid cells – either T cells or, more commonly, B cells – originating in the 
lymphoid tissue.  Lymphoid tissue is found in many places throughout the body.  As a 
result, there are many different kinds of NHL that can originate almost anywhere in the 
body.  The various subtypes of NHL are thought to represent different diseases with 
different causes, clinical characteristics, survival rates and response to treatments (Hauke 
and Armitage, 2000; Scherr and Mueller, 1996).   
Specific information related to histology was reviewed for each individual in Grafton 
who had been diagnosed with NHL to determine if any similarities existed, which could 
suggest a common pattern related to these cancers.  In addition, a recent study examined 
the patterns and trends of NHL subtypes in the U.S. population, using six major NHL 
sub-types that included: small lymphocytic, follicular, diffuse, high-grade, peripheral T-
cell and not otherwise specified (NOS) (Groves et al, 2000).  The NOS sub-type 
represents a category of malignant lymphomas that includes cases for which more 
detailed classification is not available.   The distribution of NHL diagnoses in Grafton 
was examined using these six major subtypes and compared to the distribution of all 
Massachusetts residents diagnosed with NHL from 1982 – 2000.  A comparison of the 
distribution of NHL cases by subtype is presented in Table 11. 
The distribution of NHL diagnoses by sub-type in Grafton was generally consistent with 
the distribution in Massachusetts. The diffuse sub-type represented the most common 
type among Grafton residents with 60% diagnosed with this sub-type during 1982 – 
2000.  The percentage of individuals with the diffuse and small lymphocytic sub-types of 
NHL in Grafton was greater than observed in the state (see Table 11).  Specifically, the 
percentage of individuals in Grafton with the diffuse type of NHL was 60% while the 
state percentage was 44.1%.  The percentage of individuals in Grafton diagnosed with the 
small lymphocytic type of NHL was 13% compared to the state percentage of 9%.  The 
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percentage of individuals with each other sub-type of NHL was less than the state 
distribution percentages.  
In CT 7383, where a statistically significant elevation of NHL was observed among 
males during the 1991 – 2000 time period, six of the eight individuals (75%) were 
diagnosed with the diffuse NHL sub-type.  The two remaining individuals were 
diagnosed with two different sub-types.   
c) Occupation 
 
The exact causes of NHL remain unknown but some occupations have been associated 
with an increased risk of developing this cancer type, specifically occupations related to 
agriculture and farming.  Farmers, herbicide and pesticide applicators, and grain workers 
appear to have the most increased risk due to more intense and prolonged exposures to 
chemicals than would be experienced by the general public (Tatham et al., 1997; Zahm, 
1990 and 1993).  Occupational information as reported to the MCR, at the time of 
diagnosis was reviewed for all residents of Grafton who were diagnosed with NHL 
during the 19-year time period of 1982 – 2000.  Review of this information revealed that 
approximately 18% of individuals reported their occupation as retired or at home.  An 
additional 9% did not have an occupation listed or their occupation was unknown at the 
time of diagnosis.  Of the remaining 73%, the majority of individuals indicated a job title 
that did not suggest an association with possible exposures related to the development of 
NHL or did not have specific enough information to determine whether their occupation 
may be associated with exposures that could possibly increase the risk of NHL.  
Occupations where exposures possibly related to an increased risk of NHL may have 
occurred were reported for two individuals in Grafton.   
d) Previous Cancer Diagnoses 
 
As mentioned above, patients who are treated with radiation therapy and/or 
chemotherapy for other cancers have a slight risk of developing secondary NHL later in 
life.  Review of data from the MCR identified seven individuals (16%) diagnosed with 
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NHL in Grafton during 1982 – 2000 who had a previous cancer diagnosis reported to the 
MCR.  These patients may have received treatment for their initial cancer that could have 
contributed to their subsequent NHL diagnosis (e.g., radiation therapy or chemotherapy).  
However, because medical records were not readily available, it is not possible to 
determine whether these individuals actually received radiation therapy or chemotherapy 
for their cancer. 
K. Geographic Distribution of the Cancer Incidence in Grafton 
 
In addition to determining census tract-specific incidence rates for each of the ten cancer 
types, a qualitative evaluation was conducted to determine whether the individuals 
diagnosed with these cancers appeared to be spatially concentrated in any one area of 
Grafton during the time period evaluated in this report, 1982 – 2000.  Specifically, place 
of residence at the time of diagnosis was mapped for all individuals diagnosed with 
cancers of the bladder, stomach, thyroid, kidney, liver, lung and bronchus, and bone as 
well as leukemia, multiple myeloma and NHL to assess any possible geographic 
concentration of cases.   
In general, review of the geographic distribution of cancer diagnoses in Grafton revealed 
no apparent spatial patterns at the neighborhood level that could not be attributed to 
factors such as areas of higher population density.  For example, although a statistically 
significant elevation of bladder cancer among males was observed in both CT 7382 and 
the town as a whole during the 1982 – 1990 time period, the diagnoses were fairly evenly 
distributed throughout the town and seemed to coincide closely with the pattern of 
population.  A similar trend was observed when looking at the distribution of residences 
of males diagnosed with NHL in the later time period when a statistically significant 
elevation occurred town-wide and in CT 7383.  Specifically, the distribution of 
individuals diagnosed with NHL varied geographically and no atypical patterns were 
noted that would suggest the presence of a common factor.       
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L. Cancer Incidence in Neighborhoods near Wyman-Gordon 
 
To further address the concerns of residents living in close proximity to the Wyman-
Gordon Company, an analysis of all types of cancer diagnosed in this neighborhood was 
completed for the years 1982 to the present.  The company is located in the northwestern 
portion of Grafton bordering the town of Millbury and the city of Worcester.  For this 
evaluation, the pattern of all cancer diagnoses was reviewed for the area that is bordered 
to the east by Hovey Pond and Northgate Court, to the south by Interstate 90 
(Massachusetts Pike), to the west by the Millbury town line and to the north by Flint 
Pond (see Figure 2).  Thirty different streets, in part or whole, are included in this area.  
In general, our review found no atypical pattern of cancer in the neighborhood 
surrounding the Wyman-Gordon Company site.  From 1982 – present, a total of 18 
different types of cancer were diagnosed among residents of this area, representing the 
occurrence of many different of diseases.   
The most commonly reported diagnoses included cancers of the lung and bronchus, 
breast, prostate, and colon/rectum.  These are the four most common types of cancer 
diagnosed among men and women in Massachusetts and this pattern is consistent with 
national and statewide trends in cancer incidence (ACS, 2002b).  Together, these cancer 
types represented more than half (59%) of the cancer diagnoses in this area.  There were 
also a number of other cancer types diagnosed among residents of this area of Grafton 
over the 22 year period reviewed including cancers of the bladder, bone, cervix, 
esophagus, kidney, liver, oral cavity and pharynx, ovary, pancreas, thyroid, and uterus as 
well as Hodgkin’s disease, leukemia, melanoma of the skin, and Non-Hodgkin’s 
Lymphoma.  However, the types of cancer that occurred varied in nature and there was 
no specific pattern or geographic concentration of any one cancer type within this 
neighborhood.  Also, the years of diagnosis for these individuals varied throughout the 22 
years reviewed, indicating no apparent trend or pattern in the time of diagnosis. 
The majority of cancer types diagnosed among residents of the neighborhood 
surrounding the Wyman-Gordon Company site are predominantly associated with non-
environmental factors such as family history, smoking, diet, and other lifestyle behaviors.  
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Because the MCR collects some information related to risk factors (e.g., smoking history) 
for individuals diagnosed with cancer, this data was reviewed to better characterize the 
incidence patterns of cancer in this area of Grafton.  This included a review of age at 
diagnosis, gender, smoking history, and occupation. 
Age is an important risk factor in many cancers.  Different cancers occur with different 
frequencies among the various age groups, and most cancer types occur more frequently 
in older populations (i.e., age 50 and over).  The average age at diagnosis among 
individuals in this neighborhood with any type of cancer was 64 and the majority of 
individuals (86%) were age 50 or older when they were diagnosed.  Review of the age 
and gender pattern among these individuals indicates that the incidence of cancer in this 
area is consistent with established prevalence patterns of disease in the general 
population.  Because cigarette smoking is also an important risk factor in the 
development of several cancer types, including cancers of the lung and bronchus, oral 
and pharynx, esophagus, colon/rectum, bladder, kidney, stomach, and pancreas, smoking 
history was reviewed for each individual in the Wyman-Gordon Company site area who 
had been diagnosed with a smoking related cancer.  Of the 44 individuals with a 
smoking-related cancer, 26 (59%) reported being current or former smokers at the time of 
diagnosis, nine were non-smokers, and smoking history was unknown for nine 
individuals.  Therefore, it is likely that smoking played a role in the development of 
cancer among some residents of the neighborhood surrounding the Wyman-Gordon 
Company.  In addition, some occupational exposures, such as jobs involving contact with 
chemicals, have been associated with an increased risk for developing certain types of 
cancer.  A review of occupation as reported to the MCR showed that some of the 
individuals diagnosed with cancer in this area of Grafton worked in jobs that could be 
related to an increased risk for developing their cancer.  Finally, analysis of the 
geographic distribution of place of residence for individuals diagnosed with cancer did 
not reveal any atypical spatial patterns that would suggest an association with a common 
factor in the town of Grafton as a whole or in the neighborhoods surrounding the 
Wyman-Gordon Company.   
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The diagnoses of several individuals who were reported to the CEH by residents who 
expressed concerns about cancer and the Wyman-Gordon Company could not be 
confirmed through the MCR.  There are several possible reasons for this.  Some of these 
individuals may have been diagnosed prior to 1982 when the MCR began collecting 
information on individuals in the state diagnosed with cancer.  It is also possible that 
some individuals resided at an address at the time of their diagnosis other than the one 
reported to the CEH by residents concerned about the Wyman-Gordon Company.  
Finally, some of these individuals may have actually been diagnosed with non-invasive 
cancer types (i.e., benign tumors) or other pre-cancerous or non-cancerous conditions.  
Such individuals would not be included in the MCR data files. 
DISCUSSION AND CONCLUSIONS 
 
According to American Cancer Society statistics, cancer is the second leading cause of 
death in Massachusetts and the United States.  Not only will one out of three people 
develop cancer in their lifetime, but this tragedy will affect three out of every four 
families.  For this reason, cancers often appear to occur in “clusters,” and it is 
understandable that someone may perceive that there are an unusually high number of 
cancer cases in their surrounding neighborhoods or towns.  Upon close examination, 
many of these “clusters” are not unusual increases, as first thought, but are related to such 
factors as local population density, variations in reporting or chance fluctuations in 
occurrence.  In other instances, the “cluster” in question includes a high concentration of 
individuals who possess related behaviors or risk factors for cancer.  Some, however, are 
unusual; that is, they represent a true excess of cancer in a workplace, a community, or 
among a subgroup of people.  A suspected cluster is more likely to be a true cancer 
cluster if it involves a large number of cases of one type of cancer diagnosed in a 
relatively short time period rather than several different types diagnosed over a long 
period of time (i.e., 20 years), a rare type of cancer rather than common types, and/or a 
large number of cases diagnosed among individuals in age groups not usually affected by 
that cancer.  These types of clusters may warrant further public health investigation. 
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Based on the information reviewed in this report, there does not seem to be an atypical 
pattern of cancer in the town of Grafton as a whole, or in any of the census tracts or the 
neighborhood surrounding the Wyman-Gordon Company site.  As mentioned previously, 
the ten cancer types evaluated were chosen based on town-wide elevations observed in 
previously published MCR reports, potential associations with contaminants of concern 
at the Wyman-Gordon Company site, and/or resident concern.  Although there were 
elevations in some cancer types during certain time periods, in general, the incidence of 
cancer occurred about as expected when compared to the state as a whole.  When 
elevations did occur, the majority were not statistically significant.  In addition, it does 
not appear that any one environmental factor played an important role in the occurrence 
of cancer during this time.  
There was a statistically significant elevation in the incidence of bladder cancer among 
males in Grafton during the earlier time period, 1982 – 1990.  However, based on the 
information reviewed, it appears that the incidence of bladder cancer has decreased over 
time.  Specifically, in the most recent time period evaluated, the incidence of bladder 
cancer occurred statistically significantly below the rate expected.  A review of available 
information on smoking status for individuals diagnosed with bladder cancer indicated 
that more Grafton residents diagnosed with bladder cancer were current or former 
smokers compared to the state as a whole.  A statistically significant elevation in the 
incidence of NHL among males occurred during the later time period in CT 7383, where 
Wyman-Gordon is located.  As mentioned previously, risk factors for this cancer type 
include age, occupation, and radiation exposure.  In addition, recent studies suggest that 
their may be a link between NHL and drinking water contaminated with nitrates (Ward et 
al., 1996).  In 1993, a nitric acid spill occurred at the Wyman-Gordon Company site that 
released 2,500 gallons of nitric acid into the groundwater.  Testing of private wells on 
Creeper Hill and Faulkner Roads showed contamination of nitrate in these wells.  The 
private wells were closed and residents were connected to town water in 1994.  Although 
NHL was statistically elevated among males in CT 7383 during the more recent time 
period, none of the individuals diagnosed with NHL had an address located on Creeper 
Hill and Faulkner Roads at the time of diagnosis.  Therefore, based on the locations of 
individuals diagnosed with NHL in this census tract and the short period of time that the 
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contaminated private wells were in use, it is very unlikely that the 1993 nitric acid spill at 
the Wyman-Gordon company site played a role in the elevation of NHL in this CT.   
In general, the analysis of the geographic distribution of place of residence for individuals 
diagnosed with cancer did not reveal any atypical spatial patterns that would suggest a 
common factor (environmental or non-environmental) is related to the incidence of 
cancer in the town of Grafton during the 19-year time period 1982 – 2000.  Moreover, no 
unusual concentrations of individuals diagnosed with cancer (including cancer types with 
a potential association with exposure to nitrates and VOCs) were observed in the vicinity 
of the Wyman-Gordon Company.   
Based on the results of this investigation, the MDPH does not recommend any further 
evaluation of cancer incidence in Grafton in relation to the Wyman-Gordon Company at 
this time.   However, the MDPH will continue to monitor the incidence of all cancer 
types in the town through city/town cancer incidence reports published by the 
Massachusetts Cancer Registry. 
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 11 9.4 117 59 -- 210 8 6.8 118 51 -- 232 3 2.6 NC NC -- NC
7382 25 20.0 125 81 -- 184 21 14.8 142 88 -- 217 4 5.2 NC NC -- NC
7383 8 11.2 71 31 -- 140 7 8.5 83 33 -- 170 1 2.8 NC NC -- NC
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 44 40.6 108 79 -- 146 36 30.0 120 84 -- 166 8 10.6 76 33 -- 149
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 1a
Bladder Cancer Incidence
Grafton, MA
1982-2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 9 4.7 193 88 -- 366 7 3.4 205 82 -- 421 2 1.2 NC NC -- NC
7382 19 9.0 212 * 127 -- 330 16 6.6 243 * 139 -- 394 3 2.4 NC NC -- NC
7383 6 5.2 115 42 -- 250 6 3.9 153 56 -- 333 0 1.3 NC NC -- NC
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 34 18.9 180 * 125 -- 252 29 14.0 208 * 139 -- 299 5 4.9 101 33 -- 236
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 1b
Bladder Cancer Incidence
Grafton, MA
1982-1990
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 2 4.4 NC NC -- NC 1 3.1 NC NC -- NC 1 1.3 NC NC -- NC
7382 6 11.1 54 20 -- 117 5 8.2 61 20 -- 142 1 2.9 NC NC -- NC
7383 2 5.6 NC NC -- NC 1 4.2 NC NC -- NC 1 1.4 NC NC -- NC
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 10 21.2 47 * 23 -- 87 7 15.6 45 * 18 -- 93 3 5.6 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 1c
Bladder Cancer Incidence
Grafton, MA
1991-2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 0 0.5 NC NC -- NC 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC
7382 0 1.3 NC NC -- NC 0 0.7 NC NC -- NC 0 0.6 NC NC -- NC
7383 0 0.6 NC NC -- NC 0 0.3 NC NC -- NC 0 0.3 NC NC -- NC
7384 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 0 2.5 NC NC -- NC 0 1.3 NC NC -- NC 0 1.1 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 2a
Bone Cancer Incidence
Grafton, MA
1982-2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
7382 0 0.6 NC NC -- NC 0 0.3 NC NC -- NC 0 0.3 NC NC -- NC
7383 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 0 1.1 NC NC -- NC 0 0.6 NC NC -- NC 0 0.5 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 2b
Bone Cancer Incidence
Grafton, MA
1982-1990
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 0 0.3 NC NC -- NC 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC
7382 0 0.7 NC NC -- NC 0 0.4 NC NC -- NC 0 0.3 NC NC -- NC
7383 0 0.3 NC NC -- NC 0 0.2 NC NC -- NC 0 0.1 NC NC -- NC
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 0 1.3 NC NC -- NC 0 0.7 NC NC -- NC 0 0.6 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 2c
Bone Cancer Incidence
Grafton, MA
1991-2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 6 5.6 108 39 -- 235 5 3.3 151  49 -- 352 1 2.2 NC NC -- NC
7382 12 12.8 94 48 -- 164 9 8.0 113 51 -- 214 3 4.8 NC NC -- NC
7383 7 6.9 101 40 -- 208 2 4.4 NC NC -- NC 5 2.5 198 64 -- 461
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 25 25.2 99 64 -- 146 16 15.7 102 58 -- 166 9 9.6 94 43 -- 179
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 3a
Kidney Cancer Incidence
Grafton, MA
1982-2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 3 2.2 NC NC -- NC 2 1.3 NC NC -- NC 1 0.9 NC NC -- NC
7382 6 4.5 132 48 -- 288 4 2.8 NC NC -- NC 2 1.7 NC NC -- NC
7383 3 2.7 NC NC -- NC 0 1.7 NC NC -- NC 3 1.0 NC NC -- NC
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 12 9.4 127 66 -- 223 6 5.8 104 38 -- 226 6 3.6 165 60 -- 359
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 3b
Kidney Cancer Incidence
Grafton, MA
1982-1990
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 3 3.2 NC NC -- NC 3 1.9 NC NC -- NC 0 1.3 NC NC -- NC
7382 6 8.6 69 25 -- 151 5 5.4 92 30 -- 215 1 3.2 NC NC -- NC
7383 4 4.0 NC NC -- NC 2 2.5 NC NC -- NC 2 1.5 NC NC -- NC
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 13 15.8 82 44 -- 140 10 9.9 102 49 -- 187 3 6.0 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 3c
Kidney Cancer Incidence
Grafton, MA
1991-2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 4 4.9 NC NC -- NC 3 2.8 NC NC -- NC 1 2.2 NC NC -- NC
7382 15 11.2 134 75 -- 221 6 6.4 94 34 -- 204 9 4.8 188 86 -- 356
7383 4 5.8 NC NC -- NC 3 3.4 NC NC -- NC 1 2.4 NC NC -- NC
7384 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Town Total† 25 22.0 114 73 -- 168 13 12.6 103 55 -- 176 12 9.4 128 66 -- 223
† Cases for which census tract designation was not possible are included in the town total.
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 4a
Leukemia Incidence
Grafton, MA
1982-2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 3 2.0 NC NC -- NC 2 1.2 NC NC -- NC 1 0.9 NC NC -- NC
7382 8 4.2 191 82 -- 376 4 2.4 NC NC -- NC 4 1.8 NC NC -- NC
7383 3 2.3 NC NC -- NC 2 1.3 NC NC -- NC 1 0.9 NC NC -- NC
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total† 15 8.6 175 98 -- 289 9 4.9 182 83 -- 346 6 3.6 166 61 -- 361
† Cases for which census tract designation was not possible are included in the town total.
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 4b
Leukemia Incidence
Grafton, MA
1982-1990
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 1 2.8 NC NC -- NC 1 1.5 NC NC -- NC 0 1.3 NC NC -- NC
7382 7 7.3 96 38 -- 197 2 4.1 NC NC -- NC 5 3.2 158 51 -- 369
7383 1 3.3 NC NC -- NC 1 1.9 NC NC -- NC 0 1.4 NC NC -- NC
7384 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total† 10 13.5 74 35 -- 136 4 7.6 NC NC -- NC 6 5.9 102 37 -- 221
† Cases for which census tract designation was not possible are included in the town total.
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 4c
Leukemia Incidence
Grafton, MA
1991-2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 0 1.4 NC NC -- NC 0 1.0 NC NC -- NC 0 0.4 NC NC -- NC
7382 3 3.1 NC NC -- NC 3 2.3 NC NC -- NC 0 0.8 NC NC -- NC
7383 2 1.7 NC NC -- NC 2 1.3 NC NC -- NC 0 0.4 NC NC -- NC
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 5 6.2 81 26 -- 189 5 4.6 110 35 -- 256 0 1.6 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 5a
Liver Cancer Incidence
Grafton, MA
1982-2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 0 0.5 NC NC -- NC 0 0.3 NC NC -- NC 0 0.1 NC NC -- NC
7382 0 1.0 NC NC -- NC 0 0.7 NC NC -- NC 0 0.3 NC NC -- NC
7383 1 0.6 NC NC -- NC 1 0.4 NC NC -- NC 0 0.2 NC NC -- NC
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 1 2.0 NC NC -- NC 1 1.4 NC NC -- NC 0 0.6 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 5b
Liver Cancer Incidence
Grafton, MA
1982-1990
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 0 0.8 NC NC -- NC 0 0.6 NC NC -- NC 0 0.2 NC NC -- NC
7382 3 2.3 NC NC -- NC 3 1.7 NC NC -- NC 0 0.5 NC NC -- NC
7383 1 1.1 NC NC -- NC 1 0.8 NC NC -- NC 0 0.3 NC NC -- NC
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 4 4.2 NC NC -- NC 4 3.1 NC NC -- NC 0 1.0 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 5c
Liver Cancer Incidence
Grafton, MA
1991-2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 35 35.6 98 68 -- 137 19 20.6 92 55 -- 144 16 15.0 106 61 -- 173
7382 77 77.8 99 78 -- 124 46 46.9 98 72 -- 131 31 31.0 100 68 -- 142
7383 43 44.3 97 70 -- 131 25 27.2 92 59 -- 136 18 17.1 105 62 -- 167
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total† 156 157.5 99 84 -- 116 91 94.5 96 78 -- 118 65 63.0 103 80 -- 131
† Cases for which census tract designation was not possible are included in the town total.
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 6a
Lung and Bronchus Cancer Incidence
Grafton, MA
1982-2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 10 15.7 64 31 -- 117 6 9.9 61 22 -- 132 4 5.8 NC NC -- NC
7382 37 30.8 120 84 -- 165 24 19.8 121 77 -- 180 13 11.0 118 63 -- 202
7383 18 18.8 96 57 -- 152 12 12.2 98 51 -- 172 6 6.6 91 33 -- 199
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 65 65.3 100 77 -- 127 42 41.9 100 72 -- 135 23 23.3 99 62 -- 148
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 6b
Lung and Bronchus Cancer Incidence
Grafton, MA
1982-1990
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 25 18.9 132 86 -- 195 13 10.1 129 69 -- 221 12 8.8 136 70 -- 237
7382 40 48.6 82 59 -- 112 22 27.6 80 50 -- 121 18 21.0 86 51 -- 136
7383 25 23.8 105 68 -- 155 13 13.7 95 50 -- 162 12 10.1 119 61 -- 208
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total† 91 91.3 100 80 -- 122 49 51.4 95 71 -- 126 42 39.9 105 76 -- 142
† Cases for which census tract designation was not possible are included in the town total.
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 6c
Lung and Bronchus Cancer Incidence
Grafton, MA
1991-2000
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 5 2.1 234 75 -- 545 3 1.1 NC NC -- NC 2 1.1 NC NC -- NC
7382 6 4.6 132 48 -- 287 4 2.4 NC NC -- NC 2 2.2 NC NC -- NC
7383 0 2.5 NC NC -- NC 0 1.4 NC NC -- NC 0 1.2 NC NC -- NC
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total† 12 9.2 130 67 -- 228 7 4.8 145 58 -- 299 5 4.4 114 37 -- 266
† Cases for which census tract designation was not possible are included in the town total.
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 2 1.0 NC NC -- NC 2 0.5 NC NC -- NC 0 0.5 NC NC -- NC
7382 2 1.8 NC NC -- NC 2 0.9 NC NC -- NC 0 0.9 NC NC -- NC
7383 0 1.1 NC NC -- NC 0 0.6 NC NC -- NC 0 0.5 NC NC -- NC
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 4 3.9 NC NC -- NC 4 2.0 NC NC -- NC 0 1.9 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 7b
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 3 1.1 NC NC -- NC 1 0.5 NC NC -- NC 2 0.6 NC NC -- NC
7382 4 2.8 NC NC -- NC 2 1.5 NC NC -- NC 2 1.3 NC NC -- NC
7383 0 1.4 NC NC -- NC 0 0.7 NC NC -- NC 0 0.6 NC NC -- NC
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total† 8 5.3 152 65 -- 299 3 2.8 NC NC -- NC 5 2.5 200 64 -- 466
† Cases for which census tract designation was not possible are included in the town total.
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 7c
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 11 8.6 128 64 -- 228 6 4.4 136 50 -- 296 5 4.2 119 38 -- 277
7382 21 19.6 107 66 -- 164 15 10.7 140 78 -- 231 6 8.9 67 25 -- 146
7383 13 10.3 126 67 -- 216 10 5.7 176 84 -- 324 3 4.6 NC NC -- NC
7384 0 0.1 NC NC -- NC 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 45 38.6 117 85 -- 156 31 20.8 149 * 101 -- 211 14 17.8 79 43 -- 132
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 8a
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 4 3.4 NC NC -- NC 1 1.8 NC NC -- NC 3 1.7 NC NC -- NC
7382 6 7.1 85 31 -- 185 4 3.8 NC NC -- NC 2 3.3 NC NC -- NC
7383 3 4.0 NC NC -- NC 2 2.2 NC NC -- NC 1 1.8 NC NC -- NC
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 13 14.5 90 48 -- 154 7 7.7 90 36 -- 186 6 6.7 89 33 -- 194
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 7 5.0 139 56 -- 287 5 2.5 198 64 -- 463 2 2.5 NC NC -- NC
7382 15 13.1 115 64 -- 189 11 7.1 154 77 -- 276 4 5.9 NC NC -- NC
7383 10 6.0 166 79 -- 305 8 3.3 243 * 105 -- 479 2 2.7 NC NC -- NC
7384 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 32 24.2 132 90 -- 187 24 13.0 185 * 118 -- 275 8 11.2 71 31 -- 141
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 3 4.9 NC NC -- NC 2 3.0 NC NC -- NC 1 1.9 NC NC -- NC
7382 9 10.4 86 39 -- 164 7 6.6 106 42 -- 218 2 3.8 NC NC -- NC
7383 6 5.7 105 38 -- 229 5 3.7 134 43 -- 313 1 2.0 NC NC -- NC
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 18 21.0 86 51 -- 135 14 13.3 105 57 -- 177 4 7.7 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 9a
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 0 2.5 NC NC -- NC 0 1.5 NC NC -- NC 0 0.9 NC NC -- NC
7382 5 4.8 105 34 -- 245 4 3.0 NC NC -- NC 1 1.8 NC NC -- NC
7383 2 2.7 NC NC -- NC 1 1.8 NC NC -- NC 1 0.9 NC NC -- NC
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 7 9.9 70 28 -- 145 5 6.3 80 26 -- 187 2 3.7 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 9b
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 3 2.3 NC NC -- NC 2 1.4 NC NC -- NC 1 1.0 NC NC -- NC
7382 4 5.7 NC NC -- NC 3 3.7 NC NC -- NC 1 2.1 NC NC -- NC
7383 4 2.8 NC NC -- NC 4 1.8 NC NC -- NC 0 1.0 NC NC -- NC
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 11 10.9 101 50 -- 181 9 6.9 131 60 -- 249 2 4.0 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 9c
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 3 2.5 NC NC -- NC 2 0.7 NC NC -- NC 1 1.8 NC NC -- NC
7382 6 6.6 91 33 -- 198 2 1.8 NC NC -- NC 4 4.8 NC NC -- NC
7383 3 3.1 NC NC -- NC 0 0.9 NC NC -- NC 3 2.2 NC NC -- NC
7384 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 12 12.3 98 50 -- 171 4 3.4 NC NC -- NC 8 8.9 90 39 -- 178
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 10a
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 0 0.8 NC NC -- NC 0 0.3 NC NC -- NC 0 0.6 NC NC -- NC
7382 1 2.0 NC NC -- NC 0 0.6 NC NC -- NC 1 1.4 NC NC -- NC
7383 1 1.0 NC NC -- NC 0 0.4 NC NC -- NC 1 0.7 NC NC -- NC
7384 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 2 3.9 NC NC -- NC 0 1.3 NC NC -- NC 2 2.6 NC NC -- NC
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
TABLE 10b
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Census Tract Total Males Females
Obs Exp SIR Obs Exp SIR Obs Exp SIR
7381 3 1.7 NC NC -- NC 2 0.4 NC NC -- NC 1 1.3 NC NC -- NC
7382 5 4.9 103 33 -- 240 2 1.2 NC NC -- NC 3 3.6 NC NC -- NC
7383 2 2.0 NC NC -- NC 0 0.5 NC NC -- NC 2 1.5 NC NC -- NC
7384 0 0.1 NC NC -- NC 0 0.0 NC NC -- NC 0 0.0 NC NC -- NC
Town Total 10 8.6 117 56 -- 215 4 2.2 NC NC -- NC 6 6.4 94 34 -- 204
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases 95% CI = 95% Confidence Interval
Exp = Expected number of cases NC = Not calculated
SIR = Standardized Incidence Ratio * = Statistical significance
Data Source: Massachusetts Cancer Registry, Center for Health Information, Statistics, Research and Evaluation, Massachusetts Department of Public Health.
95% CI 95% CI 95% CI
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NHL subtype Grafton Massachusetts
Diffuse 60% 44.10%
Follicular 16% 17.70%
High-Grade 0% 6.40%
Not otherwise specified (NOS) 7% 18.80%
Peripheral T-cell 4% 4.10%
Small Lymphocytic 13% 9.00%
Distribution of Non-Hodgkin’s Lymphoma by Histologic Subtype
Table 11
1982 - 2000
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  ICD-O-1 and Other  
Pre-ICD-O-2 Codes 
ICD-O-2 Codes ICD-O-3 Codes 
Cancer Site / Type Site code Histology code Site code Histology code Site code Histology code 
Bladder 188.0-188.9 except 9590-9980 C67.0-C67.9 except 9590-9989 C67.0-C67.9 except 9590-9989 
Bone 170.0-170.9 except O8010-
O8140, O8723, 
O9391-O9580, 
O9590-O9980, 
B9593-B9733 
C40.0-C41.9 except 8010-8140, 
8723, 9391-9580, 
9590-9980 
C40.0-C41.9 except 9590-9989 
Kidney &  
Renal Pelvis 
189.0, 189.1 except 9590-9980 C64.9, C65.9 
 
except 9590-9989 C64.9, C65.9 
 
except 9590-9989 
Leukemia 
 
 
 
 
140.0-199.9 
 
includes O9800-
O9943, O9951, 
P9803-P9943, 
B9803-B9943 
1. C00.0-C80.9 
 
 
AND 
2. C42.0, C42.1, 
C42.4 
1. includes 9800-
9822, 9824-9826, 
9828-9941 
 
2. includes 9823, 
9827 
1. C00.0-C80.9 
 
 
 
AND 
2. C42.0, C42.1, 
C42.4 
1. includes 9733, 
9742, 9800-9820, 
9826, 9831-9948, 
9963-9964 
 
2. includes 9823, 
9827 
Liver 155.0 except 9590-9980 C22.0 except 9590-9989 C22.0 except 9590-9989 
Lung & Bronchus 
 
162.2-162.9 
 
except 9050-9053, 
9590-9980 
C34.0-C34.9 
 
except 9590-9989 C34.0-C34.9 
 
except 9590-9989 
Multiple Myeloma 140.0-199.9 includes O9730-
O9732, P9733, 
B9733 
C00.0-C80.9 includes 9731, 
9732 
C00.0-C80.9 includes 9731, 
9732, 9734 
Non-Hodgkin's 
Lymphoma (NHL) 
 
 
 
 
 
140.0-199.9 
 
includes O9590-
O9642, O9670-
O9710, O9750, 
P9593-P9643, 
P9693-P9713, 
P9753, B9593-
B9643, B9703 
1. C00.0-C80.9 
 
AND 
2. All sites 
except C42.0, 
C42.1, C42.4 
1. includes 9590-
9595, 9670-9717 
 
2. includes 9823, 
9827 
1. C00.0-C80.9 
 
AND 
2. All sites 
except C42.0, 
C42.1, C42.4 
1. includes 9590-
9596, 9670-9729 
 
2. includes 9823, 
9827 
Stomach 151.0-151.9 except 9590-9980 C16.0-C16.9 except 9590-9989 C16.0-C16.9 except 9590-9989 
Thyroid 193.9 except 9590-9980 C73.9 except 9590-9989 C73.9 except 9590-9989 
*Note:  Includes invasive tumors only, selected by excluding in situ stages J0, S0, TTISNXM0, TTANXMX, TTANXM0, TTAN0MX, TTISN0M0, 
TTISNXMX, TTISN0MX, TTISN0M0, TTIN0M0, TTIN0MX, TTINXM0, and TTINXMX (1982-1994 data) or by specifying behavior code (1995-2000 data). 
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Bladder Cancer 
 
The American Cancer Society estimates that bladder cancer will affect 60,240 people in 
the U.S. in 2004, accounting for 6% of all cancers diagnosed in the United States among 
men and 2% among women.  In Massachusetts, bladder cancer accounts for 
approximately 5% of all cancers diagnosed among males and females combined (ACS, 
2004).  Males are three times more likely to develop bladder cancer than females and 
whites are two times more likely to develop this disease than blacks.  The risk of bladder 
cancer increases with age and the mean age at diagnosis is 68-69 years (ACS, 2000). 
 
The greatest risk factor for bladder cancer is cigarette smoking.  Smokers are more than 
twice as likely to develop bladder cancer compared to nonsmokers (ACS, 2000).  The 
risk of developing bladder cancer increases with the number of packs smoked per day and 
with duration of smoking.  Further, the risk of bladder cancer may be higher in women 
than in men who smoke comparable numbers of cigarettes (Castelao et al., 2001).  
Approximately 25-60% of all bladder cancers can be attributed to tobacco use (Johansson 
and Cohen, 1997).  Smoking cessation has been found to reduce the risk of developing 
bladder cancer by 30% to 60% (Silverman et al., 1996). 
 
Studies have also revealed a number of occupations that are associated with bladder 
cancer.  In fact, exposures to chemicals in the workplace account for an estimated 20-
25% of all bladder cancers diagnosed among men in the U.S. (Johansson and Cohen, 
1997).  Occupational exposure to aromatic amines, such as benzidine and 2-
naphthylamine, increases the risk of bladder cancer (ACS, 2000).  These chemicals were 
common in the dye industry in the past.  A higher risk of bladder cancer has also been 
observed among aromatic amine manufacturing workers as well as among workers in the 
rubber, leather, textiles, printing, and paint products industries (ACS, 2000; Silverman et 
al., 1996).  The development of new chemicals, changed worker exposures, and the 
elimination of many known bladder carcinogens in the workplace have caused shifts in 
those occupations considered to be high risk.  For example, risks among dye, rubber, and 
leather workers have declined over time, while other occupations such as motor vehicle 
operation (e.g., drivers of trucks, buses, and taxis) and the aluminum industry have 
emerged as potential high-risk occupations (Silverman et al., 1996).  However, specific 
occupational exposures in these occupations have not been confirmed and study findings 
are not consistent.  Further, the risk of bladder cancer from occupational exposures may 
be increased among smokers (ACS, 2000). 
 
Dietary factors such as consumption of fried foods as well as foods high in fat and 
cholesterol have been found to be associated with increased bladder cancer risk 
(Silverman et al., 1996).  Use of the Chinese herb, Aristocholia fangchi, found in some 
dietary supplements, has also been linked with bladder cancer (ACS, 2000).  Use of some 
anti-cancer drugs (e.g., cyclophosphamide and chlornaphazine), use of phenacetin, and 
infection with Shistosoma haematobium (a parasite found in Africa) are thought to be 
associated with the development of bladder cancer, however, not all epidemiological 
studies have produced convincing findings (Silverman et al., 1996). 
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Other risk factors for bladder cancer include a personal history of bladder cancer, certain 
rare birth defects involving the bladder, and exposure to ionizing radiation (ACS, 2000; 
Silverman et al., 1996).  Exposure to chlorinated by-products in drinking water has also 
been suggested to increase bladder cancer risk, however, a recent population-based study 
found that an association was present only among smokers (Cantor et al., 1998). 
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Non-Hodgkin’s Lymphoma 
 
Lymphomas are cancers involving the cells of the lymphatic system.  The majority of 
lymphomas involve the lymph nodes and spleen but the disease may also affect other 
areas within the body.  Non-Hodgkin’s lymphoma (NHL) is a classification of all 
lymphomas except Hodgkin’s disease.  Thus NHL is a mixed group of diseases that is 
characterized by the malignant increase in specific cells of the immune system (B or T 
lymphocytes).  B-cell lymphomas are more common than T-cell lymphomas, accounting 
for about 85% of all cases of NHL (ACS, 2003).  The various types of NHL are thought 
to represent different diseases with different causes (Scherr and Mueller, 1996).  NHL 
can occur at all ages, however, the average age at diagnosis is in the early 60s and the 
incidence of this disease generally increases with age.  This disease is more common in 
men than in women and affects whites more often than African Americans or Asian 
Americans (ACS, 2003).  The American Cancer Society estimates that approximately 
54,370 Americans will be diagnosed with NHL in 2004, making it the sixth most 
common cancer in the U.S. among both men and women, excluding non-melanoma skin 
cancers (ACS, 2004). 
 
Overall, between 1973 and 1997, the incidence of NHL in the U.S. grew 81% (Garber, 
2001), although during the 1990s, the rate of increase appears to have stabilized (ACS, 
2004).  In Massachusetts, the incidence of NHL increased 50% during 1982-1997 from 
10.5 cases per 100,000 to 15.7 cases per 100,000 (MCR, 1997 and 2000).  The increase in 
NHL incidence has been attributed to better diagnosis, greater exposure to causative 
agents, and, to a lesser extent, the increasing incidence of AIDS-related lymphomas 
(Devesa and Fears, 1992; Scherr and Mueller, 1996).  Although the primary factors 
related to the development of NHL include conditions that suppress the immune system, 
viral infections, and certain occupational exposures, these factors are thought to account 
for only a portion of the increase observed in this cancer type (Scherr and Mueller, 1996).  
The observation that the rate of increase is declining for NHL may be attributed in part to 
increased use of antiretroviral therapy to slow HIV progression (Wingo et al., 1998). 
 
NHL is more common among people who have abnormal or compromised immune 
systems, such as those with inherited diseases that suppress the immune system, 
individuals with autoimmune disorders, and people taking immunosuppressant drugs 
following organ transplants.  Genetic predisposition (e.g., inherited immune deficiencies) 
only accounts for a small proportion of NHL cases (Scherr and Mueller, 1996).  AIDS 
patients have a 100- to 300-fold higher risk for NHL than the general population (again, 
these cases account for only a minor part of overall NHL incidence) (Garber, 2001).  
NHL has also been reported to occur more frequently among individuals with conditions 
that require medical treatment resulting in suppression of the immune system, such as 
cancer chemotherapy.  However, current evidence suggests that the development of NHL 
is related to suppression of the individual’s immune system as a result of treatment, rather 
than the treatment itself (Scherr and Mueller, 1996). 
 
Several viruses have been shown to play a role in the development of NHL.  Among 
organ transplant recipients, suppression of the immune system required for acceptance of 
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the transplant leads to a loss of control or the reactivation of viruses that have been 
dormant in the body (e.g., Epstein-Barr Virus [EBV] and herpesvirus infections).  In 
addition, because cancer-causing viruses are known to cause lymphomas in various 
animals, it has been proposed that these types of viruses may also be associated with the 
development of NHL among humans without compromised immune systems.  Infection 
with the human T-cell leukemia/lymphoma virus (HTLV-I) is known to cause T-cell 
lymphoma among adults.  However, this is a relatively rare infection and most likely 
contributes only a small amount to the total incidence of NHL (Scherr and Mueller, 
1996).  EBV infection is common among the general population and has been shown to 
play a role in the development of most cases of transplant and AIDS related NHL.  The 
combination of immune system deficiencies and EBV infection may cause some people 
to develop NHL (ACS, 2003).  Although viruses are causal factors for some subtypes of 
NHL, to date, studies have shown that the role of EBV in the development of NHL in the 
general population may not be large (Scherr and Mueller, 1996).  Moreover, the high 
prevalence of EBV in the general population suggests that EBV may be only one of 
several factors in the development of this cancer. 
 
Recent studies have found that a type of bacteria, Helicobacter pylori, a common cause of 
stomach ulcers, can also cause some lymphomas of the stomach (ACS, 2003).  An 
important implication of this finding is that treatment with antibiotics could prevent some 
NHL of the stomach. 
 
Some occupations have been associated with an increased risk of developing NHL, such 
as occupations related to chemicals or agriculture.  Farmers, herbicide and pesticide 
applicators, and grain workers appear to have the most increased risk (Zahm, 1990 and 
1993; Tatham et al., 1997).  Studies conducted among agricultural workers have 
demonstrated increases in NHL among those using herbicides for more than 20 days per 
year and individuals who mix or apply herbicides.  A greater incidence of NHL appears 
to be related specifically to exposure to the herbicide 2,4-dichlorophenoxyacetic acid 
(2,4-D) and organophosphate insecticides (Wigle et al., 1990; Zahm et al., 1990; Zahm et 
al., 1993).  Further studies of exposure to these chemicals and NHL incidence have 
shown that the increased risk is attributed to a specific impurity, 2,3,7,8-
tetrachlorodibenzo-p-dioxin or 2,3,7,8-TCDD, present in these herbicides.  However, 
reports of accidental industrial exposures to TCDD alone have not demonstrated an 
increased risk of NHL (Scherr and Mueller, 1996).  An elevated risk for NHL 
development has also been noted among fence workers, orchard workers, and meat 
workers.  High-dose exposure to benzene has been associated with NHL (ACS, 2003), 
however, a recent international cohort study indicated that petroleum workers exposed to 
benzene were not at an increased risk of NHL (Wong and Raabe, 2000). 
 
In addition, epidemiological studies of long-term users of permanent hair coloring 
products have suggested an increased incidence of NHL (Zahm et al., 1992; Scherr and 
Mueller, 1996).  However, a recent population based study found no association between 
the use of hair color products and an increased risk of developing NHL.  The researchers 
further stated that results from this study and previous studies, including experimental 
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animal studies, provide little convincing evidence linking NHL with normal use of hair 
dye (Holly et al., 1998). 
 
Although radiation (e.g., nuclear explosions or radioactive fallout from reactor accidents) 
has been implicated in the development of some cancers, including NHL (ACS, 2003), 
there is little evidence for an increased risk of lymphoma due to radiation (Scherr and 
Mueller, 1996). 
 
Recent studies have suggested that contamination of drinking water with nitrate may be 
associated with an increased risk of NHL (Ward et al., 1996).  Nitrate forms N-nitroso 
compounds which are known carcinogens and can be found in smoked or salt-dried fish, 
bacon, sausages, other cured meats, beer, pickled vegetables, and mushrooms. 
 
Smoking has also been suggested to increase the risk of NHL.  A study that evaluated the 
history of tobacco use and deaths from NHL determined that people who had ever 
smoked had a two-fold increase of dying from NHL as compared to those who never 
smoked.  Further, a four-fold increase was found among the heaviest smokers (Linet et 
al., 1992).  In addition, a more recent study that primarily examined occupation and NHL 
risk found a significant association with high levels of cigarette smoking and all NHL 
types (Tatham et al., 1997).  However, a recent review of 5 cohort studies and 14 case-
control studies concludes that results of epidemiological studies have been inconsistent 
and that smoking has not been determined to be a definitive risk factor in the 
development of NHL (Peach and Barnett, 2000). 
 
A recent Danish study has linked the use of tricyclic and tetracyclic antidepressants to 
NHL, however, more research is needed on this possible association (Dalton et al., 2000). 
 
Although NHL is associated with a number of risk factors, the causes of this disease 
remain unknown.  Most patients with NHL do not have any known risk factors (ACS, 
2003). 
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